In the Opioid Epidemic, Treatment Challenges Still Persist
Drug Topics
OCTOBER 20, 2023
Despite societal need, stigma around MAT and MOUD still exists.
Drug Topics
OCTOBER 20, 2023
Despite societal need, stigma around MAT and MOUD still exists.
Pharmacy Times
OCTOBER 20, 2023
The statistically significant and clinically meaningful improvement in disease-free survival is “practice-changing” and may represent a “paradigm shift” in treatment, according to experts.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 20, 2023
When she stopped getting her period in March 2022, Daryn Schwartz wasn’t especially concerned. At 42, she had recently come off birth control, and figured her cycles were still adjusting. When it hadn’t come back by the summer, she sought gynecological care, but was told to wait it out. So she did, with no changes. She was having other symptoms, too — fatigue, chronic pain, and difficulty focusing.
Pharmacy Times
OCTOBER 20, 2023
Penbraya (Pfizer Inc) is the first and only approved pentavalent vaccine that confers protection against the most common meningococcal serogroups—A, B, C, W-135, and Y, in individuals 10 through 25 years of age.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
OCTOBER 20, 2023
Three out of four Americans don’t trust artificial intelligence in a healthcare setting, and most have no idea whether their provider is already using the technology, a new survey has found. | Many respondents admitted their understanding of AI is limited, and half would not be comfortable with it in the healthcare setting. But most said if their practice was transparent about its AI use, that would help them feel more comfortable.
Pharmacy Times
OCTOBER 20, 2023
In a recent study, approximately 99% of children who received solid organ transplant and live vaccination against rubella had antibodies 1 to 3 months post-vaccination.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 20, 2023
What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars? At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology , which was acquired by Eli
Pharmacy Times
OCTOBER 20, 2023
Women with HIV reported higher rates of physical abuse than men with HIV, but women had more social support from family and friends.
STAT
OCTOBER 20, 2023
Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated. In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point
Pharmacy Times
OCTOBER 20, 2023
In addition to celebrating his colleagues, Medrano said he is taking more time for mindfulness and meditation before going to work each day.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
OCTOBER 20, 2023
Ongoing national medication, medical supply and medical equipment shortages are harming patients, a new survey reveals. | Providing appropriate care has become increasingly difficult, leading to instances of unsafe practices, compromised care and harmful, otherwise avoidable patient safety incidents, the survey found.
Fierce Pharma
OCTOBER 20, 2023
Eli Lilly is on a roll with its RET inhibitor Retevmo, with new trial results showing the drug can offer dramatic benefits in the treatment of certain lung and thyroid cancers. | Eli Lilly is on a roll with its RET inhibitor Retevmo, with new trial results showing the drug can offer dramatic benefits in the treatment of certain lung and thyroid cancers.
Fierce Healthcare
OCTOBER 20, 2023
Kaiser Permanente is expanding its medical-legal partnership program to bring housing-related legal services to members and communities across seven of its regions. | The program is in partnership with the National Center for Medical-Legal Partnership and Health Begins. The partners estimate they can help prevent evictions and access housing-related legal aid for thousands of community residents and Kaiser members by 2025.
STAT
OCTOBER 20, 2023
NEW ORLEANS — The annual meeting of the American Society of Reproductive Medicine is usually a buoyant, shiny parade of new science, fresh technology products, and promises that together they will provide more people with more options than ever before for taking control of how and when, and if, they have children. This year’s event still bore the familiar trappings of hope — 8-foot-high photos of parents holding newborns bathed in rays of sunshine, a verdant “wishing
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
OCTOBER 20, 2023
In September, Eli Lilly filed lawsuits against eight com | Eli Lilly is going after 11 online pharmacies—including several overseas—that are allegedly importing, selling or distributing unauthorized versions of its diabetes drug Mounjaro. In a complaint filed with the U.S. International Trade Commission, Lilly has named three companies in China, three in Europe and five in the U.S. that it claims are selling “low-grade” versions of the drug.
STAT
OCTOBER 20, 2023
Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance. Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.
Fierce Healthcare
OCTOBER 20, 2023
Folx Health, a virtual provider focused on LGBTQ+ health, is now in-network with Cigna, Evernorth and Blue Shield of California. | Until August, Folx operated under a membership model in a lump sum subscription package. It has since been updated to accept insurance as a part of the core membership structure.
STAT
OCTOBER 20, 2023
The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine. The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022.
Fierce Pharma
OCTOBER 20, 2023
In the race to secure U.S. approval for the first five-pronged meningitis vaccine, Pfizer has eked out a regulatory win well ahead of its immunization rival GSK. | The U.S. FDA gave a thumbs-up to Penbraya, the commercial moniker for Pfizer’s pentavalent vaccine defending against the most common serogroups behind meningococcal disease. The shot is approved for adolescents and adults between the ages of 10 and 25.
STAT
OCTOBER 20, 2023
Abdullah Pratt was only ever interested in science and in sports because of his older brother Rashad. He saw his brother excel at what he did, but Pratt’s life changed in 2012 when his brother was shot and killed in Chicago’s South Side. “The most important thing that his life represented for me was that he relieved me of the burden to prove myself,” Pratt said.
pharmaphorum
OCTOBER 20, 2023
At CAR-TCR last month in Boston, pharmaphorum Editor in Chief Jonah Comstock grabbed some time with Tim McGuire, director of business development at biomanufacturer Resilience.
Pharmacy Times
OCTOBER 20, 2023
Biktarvy was found both effective and safe for long-term use in HIV, as well as for patients with mental health conditions.
European Pharmaceutical Review
OCTOBER 20, 2023
A paper by Tim Sandle, Head of Microbiology, Risk Management and Sterility Assurance at Bio Products Laboratory Ltd has underlined the importance of proper cleanroom disinfection practices by elucidating on the robust survival mechanism of the bacterium Micrococcus luteus (M. luteus). As “one of the most abundant organisms on the outer layer of human skin” M. luteus is a common contaminant recovered from cleanrooms, according to Sandle.
Pharmacy Times
OCTOBER 20, 2023
An overview of updated CDC ACIP recommendations for COVID-19 vaccines available through commercial channels for the 2023-2024 season.
STAT
OCTOBER 20, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Drug Store News
OCTOBER 20, 2023
According to a report, sales gains were broad-based on the month, with the biggest increase coming at miscellaneous store retailers, which saw an increase of 3%, and online sales rose 1.1%.
STAT
OCTOBER 20, 2023
As demand for weight-loss treatments intensifies, Eli Lilly has filed a complaint with the U.S. International Trade Commission against nearly a dozen online pharmacies that are allegedly selling unapproved versions of the Mounjaro diabetes drug, which is frequently used to combat obesity. The drugmaker maintained the companies are marketing “low grade” versions of products purporting to contain tirzepatide, which is the active pharmaceutical ingredient in Mounjaro.
The Checkup by Singlecare
OCTOBER 20, 2023
Shilajit, also called mumie or mineral pitch, is a mineral-rich, sticky substance typically found in the rocks of the Himalayan mountains formed by centuries of decomposition of plants. It is gaining popularity as a dietary supplement, due to its potential health benefits, such as increasing energy levels, reducing inflammation , and improving iron deficiency anemia.
Drug Store News
OCTOBER 20, 2023
Be Delicious Orchard St was inspired by the bustling Lower East Side neighborhood in downtown New York City, which is a melting pot of street art, trendy flair and punchy flavors, the brand stated.
Drug Topics
OCTOBER 20, 2023
An ounce of prevention is well worth a pound of cure when it comes to DEA investigations.
STAT
OCTOBER 20, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda: a trip to check in on the Pharmalot ancestors, tidying up the official grounds, and some overdue promenading with the official mascots. If time permits, we may also hold a listening party and, if so, the playlist may include this , this , this and this.
Fierce Pharma
OCTOBER 20, 2023
With a new chief operating officer and an ongoing generics hit to its longtime stalwart Xyrem, Jazz Pharma has been going through some changes this year. | The company is in talks with advisors to field interest in a potential sale, people with knowledge of the matter told Bloomberg. Other options include breaking up the business and divesting some key assets.
Fierce Healthcare
OCTOBER 20, 2023
Prospect Medical Holdings has approximately nine months to sell off its struggling four-hospital system Crozer Health under a newly struck agreement between the private equity firm and the Pennsylv | The private equity firm was embroiled in a lawsuit over its closure of a Crozer Health hospital, which it said was necessary due to millions in monthly losses.
Fierce Pharma
OCTOBER 20, 2023
At ESMO, Merck is encouraged by Welireg's potential to treat clear cell renal cell carcinoma (ccRCC), a common type of kidney cancer.
Let's personalize your content